Pulmonx
Young Lee has a diverse work experience in medical device start-ups and sales roles. Young has held positions such as Regional Business Director at Pulmonx Corporation, where they built and led a successful sales team. At NxThera, they served as a Regional Business Manager and played a crucial role in commercializing a novel urology treatment. Young also worked as a Regional Business Manager at Acclarent, focusing on ENT products and developing an in-office commercial strategy. In addition, Young Lee has experience in sales roles at SurgRx, Hologic Inc., CONMED Corporation, and WorldCom.
Young Lee earned a Bachelor of Science degree in Interdisciplinary Studies with a focus on Marketing/Advertising and a minor in Communications from Old Dominion University. No specific start or end years were provided for this education.
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1